Masahiro Mitsuoka

Prognostic Value of Programmed Death Ligand 1 and Programmed Death 1 Expression in Thymic Carcinoma

Shintaro Yokoyama, Hiroaki Miyoshi, Kazutaka Nakashima et al. · Clinical Cancer Research · 2016 · 82 citations · Full text

Medicine, Oncology, Pathology +17

Clinicopathologic and Prognostic Implications of Programmed Death Ligand 1 Expression in Thymoma

Shintaro Yokoyama, Hiroaki Miyoshi, Tatsuya Nishi et al. · The Annals of Thoracic Surgery · 2016 · 69 citations · Full text

Medicine, Oncology, Pathology +14

Co-existence of positive MET FISH status with EGFR mutations signifies poor prognosis in lung adenocarcinoma patients

Aya Tanaka, Naoko Sueoka‐Aragane, Tomomi Nakamura et al. · Lung Cancer · 2011 · 64 citations

Medicine, Molecular Genetics, Oncology +9

Clinical benefits and complications of Dumon stent insertion for the treatment of severe central airway stenosis or airway fistula

Masahiro Mitsuoka, Tohru Sakuragi, Tsuyoshi Itoh · General Thoracic and Cardiovascular Surgery · 2007 · 48 citations

Medicine, Surgery, Pulmonology +13

Modified Dumon stent for the treatment of a bronchopleural fistula after pneumonectomy

Kohsuke Tayama, Naofumi Eriguchi, Yasuhiko Futamata et al. · The Annals of Thoracic Surgery · 2003 · 46 citations · Full text

Medicine, Clinical Sciences, Surgery +8